PYPD — Polypid Income Statement
0.000.00%
Last trade - 00:00
- $16.45m
- $10.72m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 18.6 | 26.3 | 43.1 | 38.9 | 22.9 |
Operating Profit | -18.6 | -26.3 | -43.1 | -38.9 | -22.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.91 | -36.9 | -42.6 | -39.4 | -23.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.91 | -36.9 | -42.6 | -39.6 | -23.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.91 | -36.9 | -42.6 | -39.6 | -23.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.91 | -39 | -42.6 | -39.6 | -23.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -12.8 | -62.6 | -67.4 | -60.5 | -16.8 |
Dividends per Share |